生物技术是我国战略性高新技术发展领域，也是全球各国在生物经济时代能否获胜的关键技术。本文通过科学引文索引数据库（SCI）中论文收录文献的文献计量学研究，对单克隆抗体、疫苗、重组蛋白、基因治疗、干细胞研究、组织工程、基因组学、蛋白质组学、芯片技术九类关键技术领域的全球研究分布格局进行了探讨，并结合生物医药产业链进行定标比超研究，以期发现我国在全球生物技术领域所处的位置和产业差距。研究发现美国在以上关键技术领域均处于全球绝对领先地位，而我国在某些技术领域如芯片、组织工程、组学等领域已具有一定比较优势和国际竞争能力，但在较长时期内研发和产品仍将处于跟随地位。
Biotechnology is a strategic development area, and also a key competitive technology to wining advantage in bioeconomic era globally. From online Science Citation Index (SCI) database we performed nine critical technology bibliometrics recombinant protein, monoclonal antibody, vaccine, stem cell, genetic therapy, tissue engineering, biochips, genomics, proteomics by country for benchmarking. Meanwhile, Industry chain gap was also discussed combined with biotechnology product and industry status ,to find gaps between China and developed country and the position of China in global biotechnology landscape. Statistics show American wined Absolute Advantage in all areas , China had some comparative capability in biochips ,bioengineering and Omics area, and will be a follower in a long period of time in biotechnology research and development.
吴曙霞,雷霆,武士华. 主要发达国家生物技术关键领域SCI计量对比研究[J]. 中国生物工程杂志, 2007, 27(6): 130-136.
. Sci bibliometrics contrast research on critical biotechnology area of Main country. China Biotechnology, 2007, 27(6): 130-136.
https://manu60.magtech.com.cn/biotech/CN/ 或 https://manu60.magtech.com.cn/biotech/CN/Y2007/V27/I6/130
Cited
